Bacil Pharma Limited (BOM:524516)
16.87
+0.07 (0.42%)
At close: Nov 16, 2026
Bacil Pharma Market Cap
Bacil Pharma has a market cap or net worth of 242.14 million as of November 17, 2026. It is the 47,212th most valuable company in the world and the 4,584th biggest in India. Its market cap has decreased by 45.33% in one year.
Market Cap
242.14M
Enterprise Value
287.62M
Revenue
n/a
Global Rank
Country Rank
#4,584 India
PE Ratio
19.67
ChartMarket Cap Chart
Since April 23, 2007, Bacil Pharma's market cap has increased from 21.80M to 242.14M, an increase of 1,010.66%. That is a compound annual growth rate of 13.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 240.27M | -53.03% |
| Dec 31, 2025 | 511.54M | 59.83% |
| Dec 31, 2024 | 320.06M | 751.72% |
| Dec 29, 2023 | 37.58M | -32.13% |
| Dec 23, 2022 | 55.37M | 31.47% |
| Dec 31, 2021 | 42.11M | 51.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Auro Laboratories | 1.46B |
| Panchsheel Organics | 1.41B |
| Krebs Biochemicals & Industries | 1.27B |
| Tyche Industries | 1.06B |
| Vasundhara Rasayans | 388.69M |
| Alfavision Overseas (India) | 332.91M |
| Crestchem | 298.80M |
| Ishita Drugs and Industries | 217.57M |